组织工程技术耳鼻再造多中心临床研究

注册号:

Registration number:

ChiCTR2000036707 

最近更新日期:

Date of Last Refreshed on:

2020-09-20 01:33:03 

注册时间:

Date of Registration:

2020-08-24 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

组织工程技术耳鼻再造多中心临床研究

Public title:

Multi-center clinical study of ear & nose reconstruction using tissue engineering cartilage transplantation

注册题目简写:

English Acronym:

研究课题的正式科学名称:

组织工程技术耳鼻再造多中心临床研究

Scientific title:

Multi-center clinical study of ear & nose reconstruction using tissue engineering cartilage transplantation

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

张伟 

研究负责人:

周广东 

Applicant:

Wei Zhang 

Study leader:

Guangdong Zhou 

申请注册联系人电话:

Applicant telephone:

+86 13455658575

研究负责人电话:

Study leader's
telephone:

+86 13818248439

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

zhangwei@wfmc.edu.cn

研究负责人电子邮件:

Study leader's E-mail:

guangdongzhou@126.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

上海市制造局路639号

研究负责人通讯地址:

上海市制造局路639号

Applicant address:

639 Zhizaoju Road, Shanghai, China

Study leader's address:

639 Zhizaoju Road, Shanghai, China

申请注册联系人邮政编码:

Applicant postcode:

200011

研究负责人邮政编码:

Study leader's postcode:

200011

申请人所在单位:

上海交通大学医学院附属第九人民医院

Applicant's institution:

Shanghai Ninth People's Hospital affiliated to Shanghai Jiao Tong University School of Medicine

研究负责人所在单位:

上海交通大学医学院附属第九人民医院

Affiliation of the Leader:

Shanghai Ninth People's Hospital affiliated to Shanghai Jiao Tong University School of Medicine

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

SH9H-2020-T237-1

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

上海交通大学医学院附属第九人民医院医学伦理委员会

Name of the ethic committee:

Ethical Committee of Shanghai Ninth People's Hospital affiliated to Shanghai Jiao Tong University School of Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

2020-08-13 00:00:00

伦理委员会联系人:

甄红

Contact Name of the ethic committee:

Hong Zhen

伦理委员会联系地址:

上海市制造局路639号

Contact Address of the ethic committee:

639 Zhizaoju Road, Shanghai, Chin

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

上海交通大学医学院附属第九人民医院

Primary sponsor:

Shanghai Ninth People's Hospital affiliated to Shanghai Jiao Tong University School of Medicine

研究实施负责(组长)单位地址:

上海市制造局路639号

Primary sponsor's address:

639 Zhizaoju Road, Shanghai, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

上海交通大学医学院附属第九人民医院

具体地址:

制造局路639号

Institution
hospital:

Shanghai Ninth People's Hospital affiliated to Shanghai Jiao Tong University School of Medicine

Address:

639 Zhizaoju Road

经费或物资来源:

国家重点项目

Source(s) of funding:

The national key project

研究疾病:

颌面畸形  

Target disease:

Maxillofacial deformities

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

单臂 

Study design:

Single arm 

研究目的:

利用组织工程成熟软骨组织再生技术,构建组织工程软骨组织以修复耳鼻缺损或发育不良。  

Objectives of Study:

To construct tissue engineering cartilage to repair the ear & nose defect or dysplasia.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

耳重建排除标准
1. 全身状态差;
2. 局部激素治疗3个月内;
3. 血液病或有出血倾向;
4. 药物成瘾(包括毒、麻药和酒精成瘾);
5. 瘢痕、过敏体质;
6. 具有传染性的病毒感染;
7. 近一个月有发热、感冒等感染症状;
8. 妇女怀孕期或哺乳期,或计划在初次登记后一年内怀孕者;
9. 有心理精神疾患,不能配合康复治疗;
10. 颅面及面神经发育差;
11. 伴有重要脏器或其他器官发育畸形者

鼻重建排除标准
1. 全身状态差,存在全身系统性疾病等手术禁忌症;
2. 颅面及面神经发育差;
3. 肿瘤患者,预期生命<5年或过去10年内患有恶性肿瘤者;
4. 患有血液系统疾病或出血倾向疾病;
5. 具有重大的活动性感染或传染性的病毒感染;
6. 妊娠期、哺乳期妇女或有妊娠意向妇女;
7. 有心理精神疾患,不能配合康复治疗;
8. 药物成瘾(包括毒、麻药和酒精成瘾);
9. 主要脏器外科手术后未满6周,或手术伤口愈合不良者;
10. 正参加其他技术临床应用项目的患者
11. 研究者认为不适合入选的其他情况。

Exclusion criteria:

Exclusion criteria of ear reconstruction
1. general condition is poor;
2. local hormone therapy within 3 months;
3. blood or bleeding tendency;
4. drug addiction (including poison, anesthetic and alcohol addiction);
5. scar, allergic constitution;
6. contagious viral infection;
7. with symptoms of fever, colds and other infections in nearly a month;
8. pregnant or lactating women, or plan in the first registration within one year after pregnancy;
9. patients with mental disorders, who can't cooperate with rehabilitation;
10. the poor development of attending craniofacial and facial nerve;
11. patients with malformations of other organs.

Exclusion criteria of nose reconstruction
1. under poor physical condition, or preexisting contraindication(s) to surgical procedure such as systemic diseases;
2. Poor craniofacial and facial nerve development;
3. Tumor patients, life expectancy <5 years or occurrence of malignant tumor within past 10 years;
4. Suffering from hematological disease or bleeding tendency disease;
5. Major active infection or infectious viral infection;
6. Pregnancy, breastfeeding or have pregnancy intentions;
7. Preexisting of mental illness and cannot cooperate with rehabilitation treatment;
8. Drug addiction (including drug, narcotic and alcohol addiction);
9. Post operation of major organs within 6 weeks , or impaired surgical wound healing;
10. Currently participating in other clinical trial;
11. Other situations that are considered not suitable for inclusion by researchers.

研究实施时间:

Study execute time:

From 2020-10-01 00:00:00 To 2025-09-23 00:00:00  

征募观察对象时间:

Recruiting time:

From 2020-10-01 00:00:00 To 2025-09-30 00:00:00

干预措施:

Interventions:

组别:

耳再造试验组

样本量:

30

Group:

Experimental Group of ear reconstruction

Sample size:

干预措施:

组织工程耳软骨重建

干预措施代码:

Intervention:

Tissue engineering ear cartilage reconstruction

Intervention code:

组别:

鼻再造试验组

样本量:

30

Group:

Experimental Group of nose reconstruction

Sample size:

干预措施:

组织工程鼻软骨重建

干预措施代码:

Intervention:

Tissue engineering nose cartilage reconstruction

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

上海 

市(区县):

 

Country:

China

Province:

Shanghai

City:

单位(医院):

上海交通大学医学院附属第九人民医院 

单位级别:

三甲 

Institution
hospital:

Shanghai Ninth People's Hospital affiliated to Shanghai Jiaotong University School of Medicine

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

体格检查

指标类型:

主要指标

Outcome:

physical examination

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

面部发育

指标类型:

主要指标

Outcome:

facial development

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

影像学

指标类型:

主要指标

Outcome:

imaging

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

化验检查

指标类型:

主要指标

Outcome:

chemistry tests

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

其他特殊检查

指标类型:

主要指标

Outcome:

other specialized examinations

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

耳软骨

组织:

耳廓

Sample Name:

auricular cartilage

Tissue:

auricle

人体标本去向

其它  

说明

用于分离耳软骨细胞制备组织工程软骨

Fate of sample:

0thers  

Note:

标本中文名:

血液

组织:

静脉

Sample Name:

Blood

Tissue:

vessel

人体标本去向

使用后销毁  

说明

用于病毒检测

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 6 years
最大 Max age 60 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

非随机对照研究

Randomization Procedure (please state who generates the random number sequence and by what method):

non-randomized study

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

N/A

Blinding:

N/A

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

ResMan, http://www.meadresman.org.cn.

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

ResMan, http://www.meadresman.org.cn.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

上海交通大学医学院附属第九人民医院院内病史系统中作为数据库,作为围手术期记录,相关医学检查、病例记录等原始数据记录

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

A standard data collection and management system include a CRF and an electronic data capture : Source record as operation record, medical exams will be repositioned in medical record system in Shanghai Ninth People's Hospital affiliated to Shanghai JiaoTong University School of Medicine

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2020-08-24 22:49:38